Search Results - "Dossat, N"

Protein biochip array technology for cytokine profiling predicts etanercept responsiveness in rheumatoid arthritis by Fabre, S, Dupuy, A.M, Dossat, N, Guisset, C, Cohen, J.D, Cristol, J.P, Daures, J.P, Jorgensen, C

“…In rheumatoid arthritis (RA) there are currently no useful indicators to predict a clinical response to tumour necrosis factor-α (TNF-α) blockade. The purpose…”
Get full text

Outcome of pN0 Triple-Negative Breast Cancers With and Without Lymph Node Irradiation by Massabeau, C, Duprez-Paumier, R, Dossat, N, Jouve, E, Lacroix Tikri, M, Filleron, T, Dalenc, F

Get full text

Protein biochip array technology to monitor rituximab in rheumatoid arthritis by Fabre, S, Guisset, C, Tatem, L, Dossat, N, Dupuy, A.M, Cohen, J.D, Cristol, J.P, Daures, J.P, Jorgensen, C

“…In rheumatoid arthritis (RA) there are currently no good indicators to predict a clinical response to rituximab. The purpose of this study was to monitor and…”
Get full text

Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes by Jacot, William, Lhermitte, Ludovic, Dossat, Nadège, Pujol, Jean-Louis, Molinari, Nicolas, Daurès, Jean-Pierre, Maudelonde, Thierry, Mangé, Alain, Solassol, Jérôme

“…Lung cancer remains the leading cause of cancer-related mortality worldwide. Currently known serum markers do not efficiently diagnose lung cancer at early…”
Get more information

Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes by Solassol, J., Jacot, W., Dossat, N., Pujol, J. L., Molinari, Nicolas, Daures, J. P., Maudelonde, T., Mange, A.

“…HYPOTHESIS: Lung cancer remains the leading cause of cancer-related mortality worldwide. Currently known serum markers do not efficiently diagnose lung cancer…”
Get full text